| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Keratin-17 | 8 | 2024 | 8 | 1.200 |
Why?
|
| Lung Neoplasms | 8 | 2024 | 702 | 1.060 |
Why?
|
| Biomarkers, Tumor | 10 | 2024 | 524 | 0.850 |
Why?
|
| Spectrophotometry, Infrared | 4 | 2016 | 25 | 0.690 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2018 | 39 | 0.560 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 187 | 0.500 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2024 | 128 | 0.470 |
Why?
|
| Immunohistochemistry | 9 | 2024 | 896 | 0.450 |
Why?
|
| Histological Techniques | 1 | 2015 | 19 | 0.440 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 39 | 0.440 |
Why?
|
| Pancreatic Neoplasms | 3 | 2024 | 354 | 0.410 |
Why?
|
| Neoplasm Proteins | 3 | 2021 | 285 | 0.410 |
Why?
|
| Pulmonary Aspergillosis | 2 | 2023 | 9 | 0.330 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 184 | 0.310 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2017 | 151 | 0.300 |
Why?
|
| Adenocarcinoma | 3 | 2019 | 364 | 0.300 |
Why?
|
| Prognosis | 7 | 2024 | 1784 | 0.250 |
Why?
|
| Endometrial Neoplasms | 2 | 2019 | 68 | 0.230 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2017 | 29 | 0.220 |
Why?
|
| Lipoma | 1 | 2025 | 17 | 0.220 |
Why?
|
| Ankle | 1 | 2025 | 27 | 0.220 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 166 | 0.220 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2024 | 9 | 0.220 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2024 | 20 | 0.220 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2023 | 5 | 0.200 |
Why?
|
| Cryptococcus neoformans | 2 | 2017 | 142 | 0.200 |
Why?
|
| Aspergillosis | 1 | 2023 | 35 | 0.200 |
Why?
|
| Esophageal Diseases | 1 | 2023 | 16 | 0.200 |
Why?
|
| Humans | 31 | 2025 | 65140 | 0.200 |
Why?
|
| Homeodomain Proteins | 1 | 2024 | 277 | 0.190 |
Why?
|
| Adenoma | 2 | 2013 | 70 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 583 | 0.190 |
Why?
|
| Drug Carriers | 2 | 2017 | 188 | 0.180 |
Why?
|
| Carcinoma, Endometrioid | 2 | 2019 | 22 | 0.170 |
Why?
|
| Microscopy | 1 | 2022 | 99 | 0.170 |
Why?
|
| Polyesters | 1 | 2021 | 45 | 0.170 |
Why?
|
| Influenza, Human | 1 | 2023 | 203 | 0.170 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2020 | 8 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2020 | 12 | 0.160 |
Why?
|
| Aspirin | 1 | 2021 | 172 | 0.150 |
Why?
|
| Cystadenofibroma | 1 | 2019 | 1 | 0.150 |
Why?
|
| V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2019 | 2 | 0.150 |
Why?
|
| Skin Neoplasms | 1 | 2024 | 408 | 0.150 |
Why?
|
| Esophageal Neoplasms | 1 | 2021 | 94 | 0.150 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 39 | 0.150 |
Why?
|
| Inflammation | 3 | 2023 | 1192 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2019 | 261 | 0.150 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2019 | 61 | 0.140 |
Why?
|
| Pancreas | 1 | 2019 | 154 | 0.140 |
Why?
|
| Pulmonary Fibrosis | 1 | 2019 | 81 | 0.140 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2019 | 62 | 0.140 |
Why?
|
| Observer Variation | 1 | 2018 | 216 | 0.140 |
Why?
|
| Lymph Nodes | 1 | 2019 | 233 | 0.140 |
Why?
|
| Squamous Intraepithelial Lesions of the Cervix | 1 | 2017 | 1 | 0.130 |
Why?
|
| Cryptococcus gattii | 1 | 2017 | 12 | 0.130 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2023 | 67 | 0.130 |
Why?
|
| Antigens, Fungal | 1 | 2017 | 58 | 0.130 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 144 | 0.130 |
Why?
|
| Female | 17 | 2025 | 34018 | 0.130 |
Why?
|
| Cervix Uteri | 1 | 2017 | 58 | 0.130 |
Why?
|
| Fungal Vaccines | 1 | 2017 | 47 | 0.130 |
Why?
|
| Interleukin-23 | 1 | 2017 | 18 | 0.130 |
Why?
|
| Fungal Proteins | 1 | 2017 | 152 | 0.130 |
Why?
|
| Cryptococcosis | 1 | 2017 | 75 | 0.120 |
Why?
|
| Eosinophils | 1 | 2017 | 49 | 0.120 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2016 | 24 | 0.120 |
Why?
|
| Hypersensitivity | 1 | 2017 | 73 | 0.120 |
Why?
|
| Interleukin-17 | 1 | 2017 | 99 | 0.120 |
Why?
|
| Eosinophilic Granuloma | 1 | 2015 | 3 | 0.120 |
Why?
|
| Knee | 1 | 2015 | 40 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2015 | 32 | 0.110 |
Why?
|
| Middle Aged | 10 | 2024 | 18273 | 0.110 |
Why?
|
| Morpholinos | 2 | 2012 | 55 | 0.110 |
Why?
|
| Male | 11 | 2025 | 31047 | 0.110 |
Why?
|
| Diagnosis, Differential | 4 | 2025 | 991 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 1 | 2015 | 195 | 0.100 |
Why?
|
| Smoking | 1 | 2019 | 862 | 0.100 |
Why?
|
| Smoking Cessation | 1 | 2019 | 553 | 0.100 |
Why?
|
| Lactation Disorders | 1 | 2013 | 4 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2019 | 1574 | 0.100 |
Why?
|
| Lung | 4 | 2023 | 966 | 0.100 |
Why?
|
| Aged | 8 | 2024 | 14965 | 0.100 |
Why?
|
| Indium Radioisotopes | 2 | 2012 | 41 | 0.100 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2013 | 12 | 0.100 |
Why?
|
| Streptavidin | 2 | 2012 | 32 | 0.100 |
Why?
|
| Survival Rate | 3 | 2021 | 844 | 0.100 |
Why?
|
| Radiopharmaceuticals | 2 | 2010 | 196 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 930 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2024 | 5614 | 0.090 |
Why?
|
| Picolinic Acids | 1 | 2012 | 7 | 0.090 |
Why?
|
| Streptococcus pyogenes | 1 | 2012 | 29 | 0.090 |
Why?
|
| Asthma | 1 | 2017 | 483 | 0.090 |
Why?
|
| Ki-67 Antigen | 1 | 2012 | 37 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 53 | 0.090 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2011 | 9 | 0.090 |
Why?
|
| Catenins | 1 | 2011 | 14 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2012 | 71 | 0.090 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2011 | 64 | 0.090 |
Why?
|
| Streptococcal Infections | 1 | 2012 | 84 | 0.090 |
Why?
|
| Antibodies | 1 | 2012 | 187 | 0.080 |
Why?
|
| Cadherins | 1 | 2011 | 90 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2011 | 62 | 0.080 |
Why?
|
| Mice | 8 | 2023 | 11119 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2011 | 203 | 0.080 |
Why?
|
| Radioisotopes | 1 | 2010 | 24 | 0.080 |
Why?
|
| Aspergillus fumigatus | 2 | 2023 | 38 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 195 | 0.080 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2011 | 207 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 203 | 0.080 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 544 | 0.080 |
Why?
|
| Disease-Free Survival | 2 | 2021 | 244 | 0.080 |
Why?
|
| DNA, Antisense | 1 | 2009 | 17 | 0.070 |
Why?
|
| Animals | 9 | 2023 | 21345 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 402 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 220 | 0.070 |
Why?
|
| Skin | 1 | 2012 | 422 | 0.070 |
Why?
|
| Adult | 6 | 2024 | 17358 | 0.070 |
Why?
|
| Cytodiagnosis | 2 | 2022 | 46 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 1113 | 0.060 |
Why?
|
| Proteins | 1 | 2012 | 764 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 790 | 0.060 |
Why?
|
| Nanoparticles | 2 | 2012 | 544 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 415 | 0.060 |
Why?
|
| Deoxycytidine | 1 | 2024 | 45 | 0.050 |
Why?
|
| Fluorouracil | 1 | 2024 | 68 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2019 | 1656 | 0.050 |
Why?
|
| Glass | 1 | 2023 | 23 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 1565 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 2023 | 83 | 0.050 |
Why?
|
| Mental Recall | 1 | 2023 | 95 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 148 | 0.050 |
Why?
|
| Esophagectomy | 1 | 2023 | 53 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2483 | 0.040 |
Why?
|
| Isotope Labeling | 2 | 2012 | 69 | 0.040 |
Why?
|
| Cytological Techniques | 1 | 2022 | 27 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 2244 | 0.040 |
Why?
|
| Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2021 | 2 | 0.040 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2021 | 12 | 0.040 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2021 | 31 | 0.040 |
Why?
|
| Mechanical Phenomena | 1 | 2021 | 24 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2021 | 134 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2019 | 5792 | 0.040 |
Why?
|
| Algorithms | 2 | 2016 | 1050 | 0.040 |
Why?
|
| Young Adult | 3 | 2017 | 4809 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 2293 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 624 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 94 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 202 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2019 | 90 | 0.040 |
Why?
|
| Mediastinum | 1 | 2019 | 28 | 0.040 |
Why?
|
| Neoplasms | 1 | 2009 | 1368 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 195 | 0.030 |
Why?
|
| Dyspnea | 1 | 2019 | 120 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 168 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 6872 | 0.030 |
Why?
|
| Vaccines, Subunit | 1 | 2017 | 40 | 0.030 |
Why?
|
| Lung Diseases, Fungal | 1 | 2017 | 34 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 2017 | 80 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 1994 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 456 | 0.030 |
Why?
|
| Glucans | 1 | 2017 | 66 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 385 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 2188 | 0.030 |
Why?
|
| Cell Separation | 1 | 2017 | 147 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 9 | 0.030 |
Why?
|
| Vibration | 1 | 2016 | 24 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 576 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 240 | 0.030 |
Why?
|
| Cell Biology | 1 | 2016 | 22 | 0.030 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2015 | 16 | 0.030 |
Why?
|
| Image-Guided Biopsy | 1 | 2015 | 50 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 710 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 641 | 0.030 |
Why?
|
| Orthopedic Procedures | 1 | 2015 | 55 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 868 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2017 | 663 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 115 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 676 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 852 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 154 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2015 | 489 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 2620 | 0.020 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2012 | 11 | 0.020 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2012 | 6 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2013 | 47 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2017 | 714 | 0.020 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2012 | 17 | 0.020 |
Why?
|
| Endometriosis | 1 | 2012 | 27 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2012 | 31 | 0.020 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2012 | 8 | 0.020 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2012 | 14 | 0.020 |
Why?
|
| Biotinylation | 1 | 2012 | 36 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2012 | 49 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 213 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 1698 | 0.020 |
Why?
|
| Multimodal Imaging | 1 | 2012 | 73 | 0.020 |
Why?
|
| Rhenium | 1 | 2010 | 8 | 0.020 |
Why?
|
| Antibodies, Neoplasm | 1 | 2010 | 27 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1640 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 232 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2010 | 87 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 149 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2012 | 202 | 0.020 |
Why?
|
| Morpholines | 1 | 2010 | 91 | 0.020 |
Why?
|
| Papillomavirus Infections | 1 | 2012 | 134 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2010 | 293 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 3485 | 0.020 |
Why?
|
| Spleen | 1 | 2010 | 474 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5429 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 625 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1163 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 204 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2009 | 286 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2012 | 325 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 1015 | 0.020 |
Why?
|
| Kidney | 1 | 2010 | 451 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 2024 | 0.020 |
Why?
|
| Cell Survival | 1 | 2009 | 587 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 2157 | 0.020 |
Why?
|
| United States | 1 | 2019 | 8093 | 0.020 |
Why?
|
| Liver | 1 | 2010 | 871 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 2372 | 0.010 |
Why?
|